MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20193101

March 5, 2024

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.1%(5ml:5mg,以C21H23NO3计)

化学药品

March 5, 2024

Company Information

Applicant Company

中国(辽宁)自由贸易试验区沈阳片区新运河路25号

Manufacturing Company

沈阳市浑南区泗水街68号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath